Zurcher Kantonalbank (Zurich Cantonalbank) - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$426,608
-22.1%
20,679
+11.4%
0.00%0.0%
Q2 2023$547,558
+41.3%
18,555
+10.3%
0.00%0.0%
Q1 2023$387,487
+13.1%
16,818
+36.5%
0.00%0.0%
Q4 2022$342,564
-3.0%
12,318
+7.0%
0.00%0.0%
Q3 2022$353,000
+4.1%
11,5080.0%0.00%0.0%
Q2 2022$339,000
-7.4%
11,508
+1.0%
0.00%0.0%
Q1 2022$366,000
-25.0%
11,390
+4.1%
0.00%0.0%
Q4 2021$488,000
+9.7%
10,944
+24.0%
0.00%0.0%
Q3 2021$445,000
-35.8%
8,826
-0.1%
0.00%
-50.0%
Q2 2021$693,000
+30.8%
8,837
-4.8%
0.00%
+33.3%
Q1 2021$530,000
-31.3%
9,283
+0.8%
0.00%
-40.0%
Q4 2020$771,000
+151.1%
9,206
+7.4%
0.01%
+150.0%
Q3 2020$307,000
+48.3%
8,5740.0%0.00%0.0%
Q2 2020$207,000
+91.7%
8,574
+38.6%
0.00%
+100.0%
Q1 2020$108,000
+80.0%
6,188
+79.5%
0.00%
Q4 2019$60,000
-21.1%
3,448
-30.9%
0.00%
-100.0%
Q3 2019$76,000
-26.9%
4,9890.0%0.00%0.0%
Q2 2019$104,000
-54.0%
4,989
-48.8%
0.00%
-50.0%
Q1 2019$226,000
+4.6%
9,748
-6.6%
0.00%0.0%
Q4 2018$216,000
+8.0%
10,436
+13.4%
0.00%0.0%
Q3 2018$200,000
+81.8%
9,199
+27.8%
0.00%
+100.0%
Q2 2018$110,000
-22.5%
7,2000.0%0.00%0.0%
Q1 2018$142,0007,2000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,460,732$240,012,00028.78%
Casdin Capital, LLC 1,500,000$48,255,0002.16%
Flagship Pioneering Inc. 2,619,968$84,284,0001.98%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 38,000$8,192,0001.85%
Yiheng Capital Management, L.P. 1,014,684$32,642,0001.49%
SECTORAL ASSET MANAGEMENT INC 207,100$6,662,0001.18%
Artal Group S.A. 600,000$19,302,0000.81%
GILDER GAGNON HOWE & CO LLC 2,619,217$84,260,0000.78%
Temasek Holdings (Private) Ltd 5,369,487$172,736,3970.73%
BRANDYWINE MANAGERS, LLC 9,601$309,0000.53%
View complete list of DENALI THERAPEUTICS INC shareholders